Medical Device Outsourcing Market Size to Reach USD 275.3 Billion by 2033

The global medical device outsourcing market size reached USD 136.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 275.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033.

Medical device outsourcing is viewed as the backbone of the global healthcare market, with the purpose of helping reduce costs for manufacturers while increasing efficiency and speeding up time to market. This allows companies to engage with specialized partners in areas such as regulatory, design, engineering, manufacturing, and packaging. The year 2025 sees rapid growth in the field due to increased healthcare demand intertwined with new innovations and regulations reshaping the conditions surrounding the industry.

One of the demanding trends in the medical device outsourcing business during 2025 is the higher complexity of the medical device.High-end companies tend to move from surgical tools designed for minimally incubated activities toward very high-tech, non-invasive diagnostic and imaging devices. This would increase the need for the companies to carry forth with their outsourcing partner using its technical know-how and state-of-the-art technology to ultimately deliver a product that is deemed to have an acceptable level of quality. This, in turn, allows the manufacturer to innovate and allow compliance with international safety regulations.

Get your Sample of Medical Device Outsourcing Market Insights for Free: https://www.imarcgroup.com/medical-device-outsourcing-market/requestsample

Cost efficiency is another major factor. Outsourcing reduces capital investment in infrastructure and enables flexible scaling of production. Many companies are shifting toward contract manufacturing organizations and design service providers to optimize resources and bring products to market faster.

Regulatory compliance remains a driving force behind outsourcing trends. As global standards continue to change, outsourcing companies offer critical support in documentation, testing, and certification to ensure devices comply with rigorous approval standards. This lowers risk and accelerates time-to-market for new products.

Furthermore, the growth of wearable products and digital health is fuelling demand for expert outsourcing services. Technology providers with expertise in miniaturization, connectivity, and software integration are leading the way in developing next-generation medical devices.

Overall, the 2025 medical device outsourcing industry is characterized by innovation, cost reduction, and cooperation. As patients and healthcare providers require more sophisticated yet inexpensive solutions, outsourcing continues to function as a strategic driver, enhancing growth, efficiency, and accessibility in the global medical device industry.

Key Market Segmentation:

Market Segmentation by Service:

• Regulatory Consulting
• Product Design and Development
• Product Testing and Sterilization
• Product Implementation
• Product Upgrade
• Product Maintenance

Market Segmentation by Therapeutics:

• Cardiology
• Diagnostic Imaging
• Orthopedic
• IVD
• Ophthalmic
• General and Plastic Surgery
• Drug Delivery
• Dental
• Endoscopy
• Diabetes Care

Market Segmentation by Application:

• Class I
• Class II
• Class III

Regional Analysis:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Who are the key players operating in the industry?

The report covers the major market players including:

• Celestica Inc. (Onex Corporation)
• Charles River Laboratories International Inc.
• Flex Ltd.
• Freyr Inc.
• Heraeus Holding GmbH
• ICON plc
• Integer Holdings Corporation
• IQVIA Inc.
• Plexus Corp.
• Sanmina Corporation
• TE Connectivity
• West Pharmaceutical Services Inc.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302